Skip to main content
OpenTrials

Clinical trial condition

Mycobacterium avium-intracellulare Infection

Explore clinical trials studying Mycobacterium avium-intracellulare Infection. Study availability and eligibility vary by location and protocol.

61 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Mycobacterium avium-intracellulare Infection trial results

Completed

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

NCT03672630

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +7 more
Locations
  • Loma Linda University Medical Center Loma Linda, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
View all 26 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease

NCT05496374

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations
  • Medical Facility Birmingham, Alabama, United States
  • Medical Facility Fresno, California, United States
  • Medical Facility Los Angeles, California, United States
  • Medical Facility Newport Beach, California, United States
View all 28 locations
View Trial Details
Completed

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

NCT04677543

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • USA008 Birmingham, Alabama, United States
  • USA062 Fresno, California, United States
  • USA048 San Diego, California, United States
  • USA050 Stanford, California, United States
View all 62 locations
View Trial Details
Completed

Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS

NCT00001047

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +21 more
Locations
  • Community Consortium of San Francisco San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Veterans Administration Med Ctr / Regional AIDS Program Washington D.C., District of Columbia, United States
  • AIDS Research Consortium of Atlanta Atlanta, Georgia, United States
View all 16 locations
View Trial Details
Completed

A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

NCT00000947

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +28 more
Locations
  • Community Consortium / Jon Kaiser Wellness Ctr San Francisco, California, United States
  • Community Consortium / UCSF San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Washington Reg AIDS Prog / Dept of Infect Dis Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

NCT00000641

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +21 more
Locations
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • St. Louis ConnectCare, Infectious Diseases Clinic St Louis, Missouri, United States
  • Washington U CRS St Louis, Missouri, United States
View all 16 locations
View Trial Details
Completed

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

NCT00001030

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +21 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
View all 42 locations
View Trial Details

Related conditions